Sensus Healthcare Announces Strategic Agreement with SkinCure Oncology
SkinCure Provides Turnkey Solution for Sensus’ SRT-100 Vision™, Aimed at Dermatology Community BOCA RATON, Fla., July 12, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation Therapy (IGSRT), today announced a strategic agreement focused on marketing the […]
Sensus Healthcare and CellMark Medical Partner to Accelerate International Expansion and Growth for Innovative Oncology and Aesthetic Solutions
BOCA RATON, Fla., July 10, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), and CellMark Medical, a global supply chain service company, today announced a new partnership to support and accelerate international growth and encourage worldwide […]
Sensus Healthcare to Join Russell Microcap® Index
BOCA RATON, Fla., June 25, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that it is set to join the Russell Microcap® Index at the conclusion of the Russell U.S. Indexes annual reconstitution, effective before […]
Sensus Healthcare to Join Russell Microcap® Index
BOCA RATON, Fla., June 25, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that it is set to join the Russell Microcap® Index at the conclusion of the Russell U.S. Indexes annual reconstitution, effective before […]
Sensus Healthcare to Participate in Panel Discussion at the Cantor Fitzgerald Dermatology & Aesthetics Summit
BOCA RATON, Fla., June 12, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that Joe Sardano, Chairman and Chief Executive Officer of Sensus Healthcare, will participate in a panel discussion, titled “New Treatments for Rare/Orphan […]
Sensus Healthcare to Participate in Panel Discussion at the Cantor Fitzgerald Dermatology & Aesthetics Summit
BOCA RATON, Fla., June 12, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that Joe Sardano, Chairman and Chief Executive Officer of Sensus Healthcare, will participate in a panel discussion, titled “New Treatments for Rare/Orphan […]
Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development
New Executive Leader Brings Extensive Clinical Research, Medical Marketing and Product Launch Experience to the Company BOCA RATON, Fla., May 8, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced the appointment of Dr. Isabelle Raymond, […]
Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development
New Executive Leader Brings Extensive Clinical Research, Medical Marketing and Product Launch Experience to the Company BOCA RATON, Fla., May 8, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced the appointment of Dr. Isabelle Raymond, […]
Sensus Healthcare Reports First Quarter Financial Results Featuring 37% Revenue Growth
Ships 21 systems with SRT-100 Vision™ systems sales continuing to rise Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., May 3, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results […]
Sensus Healthcare Reports First Quarter Financial Results Featuring 37% Revenue Growth
Ships 21 systems with SRT-100 Vision™ systems sales continuing to rise Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., May 3, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results […]
